Ropeginterferon Alfa-2b: Efficacy and Safety in Different Age Groups

Heinz Gisslinger; Christoph Klade; Pencho Georgiev; Dorota Krochmalczyk; Liana Gercheva-Kyuchukova; Miklos Egyed; Viktor Rossiev; Petr Dulicek; Arpad Illes; Halyna Pylypenko; Lylia Sivcheva; Jiri Mayer; Vera Yablokova; Kurt Krejcy; Hans C Hasselbalch; Robert Kralovics; Jean-Jacques Kiladjian

doi:10.1097/HS9.0000000000000485

Ropeginterferon Alfa-2b: Efficacy and Safety in Different Age Groups

Hemasphere. 2020 Oct 20;4(6):e485. doi: 10.1097/HS9.0000000000000485. eCollection 2020 Dec.

Authors

Heinz Gisslinger¹, Christoph Klade², Pencho Georgiev³, Dorota Krochmalczyk⁴, Liana Gercheva-Kyuchukova⁵, Miklos Egyed⁶, Viktor Rossiev⁷, Petr Dulicek⁸, Arpad Illes⁹, Halyna Pylypenko¹⁰, Lylia Sivcheva¹¹, Jiri Mayer¹², Vera Yablokova¹³, Kurt Krejcy², Hans C Hasselbalch¹⁴, Robert Kralovics¹⁵, Jean-Jacques Kiladjian¹⁶

Affiliations

¹ Medical University Vienna, Department of Internal Medicine I, Division of Haematology and Blood Coagulation, Vienna, Austria.
² AOP Orphan Pharmaceuticals AG, Vienna, Austria.
³ University Multiprofile Hospital for Active Treatment "Sveti Georgi", Clinic of Hematology, Medical University of Plovdiv, Plovdiv, Bulgaria.
⁴ University Hospital in Krakow, Teaching Unit of the Hematology Department, Krakow, Poland.
⁵ Multiprofile Hospital for Active Treatment "Sveta Marina", Clinical Hematology Clinic, Varna, Bulgaria.
⁶ Kaposi MorCounty Teaching Hospital, Department of Internal Medicine II, Kaposvar, Hungary.
⁷ Samara Kalinin Regional Clinical Hospital, Samara, Russia.
⁸ University Hospital Hradec Kralove, Department of Clinical Hematology, Hradec Kralove, Czech Republic.
⁹ University of Debrecen, Faculty of Medicine, Department of Hematology, Debrecen, Hungary.
¹⁰ Cherkasy Regional Oncology Centre, Regional Treatment and Diagnostics Haematology Centre, Department of Hematology, Cherkasy, Ukraine.
¹¹ Multiprofile Hospital for Active Treatment - HristoBotev, First Department of Internal Medicine, Vratsa, Bulgaria.
¹² University Hospital Brno, Clinic of Internal Medicine - Hematology and Oncology, Brno, Czech Republic.
¹³ Yaroslavl Regional Clinical Hospital, Department of Hematology, Yaroslavl, Russia.
¹⁴ Department of Hematology, Zealand University Hospital, Roskilde, University of Copenhagen, Denmark.
¹⁵ Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria and CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
¹⁶ Université de Paris, CIC 1427, Inserm, Paris, France and Centre d'Investigations Cliniques, AP-HP, Hospital Saint-Louis, Paris, France.

No abstract available